These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


281 related items for PubMed ID: 8891470

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Irinotecan in the treatment of colorectal cancer: clinical overview.
    Vanhoefer U, Harstrick A, Achterrath W, Cao S, Seeber S, Rustum YM.
    J Clin Oncol; 2001 Mar 01; 19(5):1501-18. PubMed ID: 11230497
    [Abstract] [Full Text] [Related]

  • 4. Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer.
    Fuchs CS, Moore MR, Harker G, Villa L, Rinaldi D, Hecht JR.
    J Clin Oncol; 2003 Mar 01; 21(5):807-14. PubMed ID: 12610178
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.
    Rothenberg ML, Eckardt JR, Kuhn JG, Burris HA, Nelson J, Hilsenbeck SG, Rodriguez GI, Thurman AM, Smith LS, Eckhardt SG, Weiss GR, Elfring GL, Rinaldi DA, Schaaf LJ, Von Hoff DD.
    J Clin Oncol; 1996 Apr 01; 14(4):1128-35. PubMed ID: 8648367
    [Abstract] [Full Text] [Related]

  • 8. [[Irinotecan--experience with second-line treatment in advanced colorectal cancer] ].
    Kristó K, Izsó J, Balatoni G, Lohinszky J, Farczádi E, Szántó J, Kofi AP, Pintér T.
    Orv Hetil; 2000 Aug 13; 141(33):1817-20. PubMed ID: 10979311
    [Abstract] [Full Text] [Related]

  • 9. Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy.
    Pitot HC, Goldberg RM, Reid JM, Sloan JA, Skaff PA, Erlichman C, Rubin J, Burch PA, Adjei AA, Alberts SA, Schaaf LJ, Elfring G, Miller LL.
    Clin Cancer Res; 2000 Jun 13; 6(6):2236-44. PubMed ID: 10873073
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [CPT-11: new drug for metastatic colorectal cancer].
    Barone C, Pozzo C, Cassano A.
    Tumori; 1999 Jun 13; 85(6):A1-11. PubMed ID: 10774581
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Irinotecan monotherapy in the treatment of colorectal cancers: results of phase II trials].
    Van Cutsem E, Peeters M.
    Bull Cancer; 1998 Dec 13; Spec No():33-7. PubMed ID: 9932082
    [Abstract] [Full Text] [Related]

  • 16. Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients.
    Abigerges D, Chabot GG, Armand JP, Hérait P, Gouyette A, Gandia D.
    J Clin Oncol; 1995 Jan 13; 13(1):210-21. PubMed ID: 7799022
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Irinotecan and mitomycin C in 5-fluorouracil-refractory colorectal cancer patients. A phase I/II study of the Southern Italy Cooperative Oncology Group.
    Comella P, Biglietto M, Casaretti R, De Lucia L, Avallone A, Maiorino L, Di Lullo L, De Cataldis G, Rivellini F, Comella G.
    Oncology; 2001 Jan 13; 60(2):127-33. PubMed ID: 11244327
    [Abstract] [Full Text] [Related]

  • 19. Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks.
    Rowinsky EK, Grochow LB, Ettinger DS, Sartorius SE, Lubejko BG, Chen TL, Rock MK, Donehower RC.
    Cancer Res; 1994 Jan 15; 54(2):427-36. PubMed ID: 8275479
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.